Table 1 Demographic data and NET characteristics of study subjects (values are given as mean ± standard deviation and range)
Demographic data and tumor characteristics | |||
|---|---|---|---|
Characteristic | n | % | |
Number of patients | 49 | 100% | |
Sex | Female | 22 | 44.9% |
Male | 27 | 55.1% | |
Age, years mean ± sd (range) | 61.7 ± 14.1 (18–83) | ||
Weight, kg mean ± sd (range) | 76.2 ± 17.1 (48–115) | ||
Injected tracer activity, MBq mean ± sd (range) | 145.1 ± 25.2 (100–212) | ||
Primary | GEP-NET total | 38 | 77.5% |
Pancreatic | 22 | 57.9% | |
Gastro-enteric | 16 | 42.1% | |
Lung | 9 | 18.4% | |
Other | 2 | 4.1% | |
NET histological sub-types | G1 | 33 | 67.4% |
G2 | 6 | 12.2% | |
G3 | 1 | 2.0% | |
Atypical carcinoid | 4 | 8.2% | |
Typical carcinoid | 5 | 10.2% | |
KI67, % mean ± sd (range) | 4.2 ± 12.9 (1–90) | ||
Number of lesions | Primary | 42 | 70.0% |
Liver metastasis | 8 | 13.3% | |
Bone metastasis | 0 | 0% | |
Lymph node metastasis | 9 | 15.0% | |
Other metastasis | 1 | 1.7% | |